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Background: ETS transcription factors regulate expression of genes involved in development and cancer.
Results: Crystal structure of the Ets-2 DNA binding domain reveals how closely spaced binding sites are recognized.
Conclusion:A significant difference in binding regulation is observed between the closely related Ets-1 and Ets-2 transcription
factors.
Significance: This may explain the different physiological roles of different Ets proteins.
Ets-2, like its closely related homologue Ets-1, is a member of
the Ets family of DNA binding transcription factors. Both pro-
teins are subject to multiple levels of regulation of their DNA
binding and transactivation properties. One such regulatory
mechanism is the presence of an autoinhibitory module, which
in Ets-1 allosterically inhibits the DNA binding activity. This
inhibition can be relieved by interaction with protein partners
or cooperative binding to closely separated Ets binding sites in a
palindromic arrangement. In this study we describe the 2.5 Å
resolution crystal structure of a DNA complex of the Ets-2 Ets
domain. The Ets domain crystallizedwith two distinct species in
the asymmetric unit, which closely resemble the autoinhibited
and DNA bound forms of Ets-1. This discovery prompted us to
re-evaluate the currentmodel for the autoinhibitorymechanism
and the structural basis for cooperative DNA binding. In con-
trast to Ets-1, in which the autoinhibition is caused by a combi-
nation of allosteric and steric mechanisms, we were unable to
find clear evidence for the allosteric mechanism in Ets-2. We
also demonstrated two possibly distinct types of cooperative
binding to substrates with Ets binding motifs separated by four
and six base pairs and suggest possible molecular mechanisms
for this behavior.
The Ets4 (E26 transformation-specific) family of transcrip-
tion factors are conserved throughout the metazoan phyla (1)
with 28 members in the human genome (2). Ets proteins share
an 85-amino acid winged helix-turn-helix DNA binding
domain (the Ets domain) that recognizes the conserved core
DNA sequence GGA(A/T) through direct polar contacts medi-
ated by residues in the highly conserved recognition helix (3).
Ets family proteins have been assigned into four classes based
on the binding preferences of up to two residues upstream and
downstream of the GGA(A/T) core (3). Class I proteins (which
include Ets-2) are by far the most widely represented, compris-
ing more than half of the human Ets proteins. Despite the sim-
ilarities in the mode and sequence specificity of DNA binding,
the functional roles and biological processes regulated by this
family of transcription factors are diverse, being able to both
activate and repress the transcription of genes involved in pro-
liferation, differentiation, and apoptosis of various cell types.
Unsurprisingly, given their importance in cellular proliferation
and cell death, a number of Ets family members, (e.g. Ets-1,
Pu-1, Etv-1, Etv-4, and Tel) are associated with tumorigenesis
and tumor progression. Various factors influence the func-
tional roles of Ets proteins, including tissue-specific expression,
alternate splicing, subcellular localization, presence of addi-
tional domains, post translational modifications, and the mod-
ulation of DNA binding through the formation of homomeric
or heteromeric interactions with protein partners.
Several of the Ets family members such as Ets-1, Ets-2, Etv-4,
Etv-5, and Etv-6 are subject to autoinhibition in which addi-
tional structural elements outside of the core Ets domain
inhibit DNA binding.Much of the knowledge of autoinhibition
in Ets family proteins comes from studies on Ets-1, which is
closely related to Ets-2 (84% sequence identity for the Ets
domains and 55% across the entire length of the polypeptide)
and, like Ets-2, contains 4 additional -helices located immedi-
ately N-terminal (HI-1 and HI-2) and C-terminal (H4 and H5)
to the core Ets domain. Deletion of these helices or expression
of an alternately spliced isoform of Ets-1, which lacks these
elements, results in a protein with increased DNA binding
affinity (4–6). Structural and functional studies have estab-
lished amechanism for the autoinhibition of Ets-1where, in the
absence of DNA, the additional helices (HI-1 HI-2 and H4 H5)
form a four-helix bundle that serves as an allosteric inhibitory
module, packing against the opposite face from the DNA bind-
ing interface (7). Upon bindingDNA the first N-terminal inhib-
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itory helix HI-1 unfolds (8, 9), forming a mostly disordered
section of randomcoil (7). The effect of this allosteric inhibition
in Ets-1 is increased by phosphorylation of serine residues
immediately N-terminal to HI-1 (10) and can be relieved by
protein-protein interactions (11, 12). A further layer of com-
plexity was added to this model when it was discovered that the
presence and phosphorylation status of an intrinsically disor-
dered serine-rich region immediately N-terminal to HI-1 was
found to stabilize the inactive state of Ets-1 to a much greater
extent (10–20-fold inhibition) than the structural transitions of
HI-1 (2–3-fold inhibition) (13, 14). A recent study established a
possible mechanism by which this inhibition proceeds, finding
that the phosphorylated serine-rich region is intrinsically dis-
ordered and forms dynamic interactions with the core Ets
domain, including regions of the DNA recognition interface
(15).
Another mechanism of regulation that is shared by both
Ets-1 and Ets-2 is the phenomenon of cooperative binding to
palindromic repeats of the Ets binding site (EBS) (16–18),
which is not generally observed in thewider Ets family proteins,
which typically bind single EBSmotifs with high affinity. Struc-
tural studies on Ets-1 bound to a palindromic EBS repeat in the
core GGA(A/T) motif separated by 4 bp (a sequence naturally
occurring on the stromelysin-1 promoter) have identified a
small predominantly polar interface between monomers that
may explain the structural basis of cooperative binding (19, 20).
Although the contact area for this interface is minimal, it is
formed from residues present in the N-terminal autoinhibitory
regions, and the stimulation of binding to cooperative sites was
found to be approximately equal to the relief of autoinhibition
(11, 19). An intriguing aspect of the structural studies of Ets-1 is
the propensity for the dynamic HI-1 inhibitory helix to associ-
ate with a neighboring Ets-1 molecule in a domain-swapped
manner. This phenomenon has been observed for both free
(PDB IDs 1MD0 (12) and 1GVJ) and DNA-bound Ets-1 struc-
tures (PDB ID 3RI4 (21), 2NNY (19), and 3MFK (20)). In one of
these structures (PDB ID 2NNY (19)) HI-1 was modeled as a
random coil; however, a re-examination of the electron density
maps reveals clear density for a domain-swapped helix similar
to that observed in PDB ID 3MFK (20). It is not clear if this
propensity for domain swapping has any functional signifi-
cance, yet the fact that it is present in multiple structures with
different crystal forms and involves the same regions that have
been shown to be important for allosteric transitions suggest
that it may have a functional importance for relief from autoin-
hibition or cooperativity.
Despite the many similarities between Ets-1 and Ets-2 in
their structural and regulatorymechanisms, the function of the
twoparalogues in vivo is distinctly different. It is clear that some
of these differences can be explained by the fact that they have
different tissue-specific expression profiles, with both proteins
expressed in a wide range of cell types, but Ets-1 is much more
highly expressed in thymus, lung, and Jurkat cells, with corre-
sponding differences in the phenotypes of knock-outmice (22).
Nevertheless, significant differences have been observed in
their transactivation activity and the protein-protein interac-
tions in which they participate; for example, Ets-2 but not Ets-1
is able to interact with both ERG (23) and CDK10 (24). To gain
insights into the structural basis for these functional differences
and to further investigate the structural basis for autoinhibition
and cooperativity, we have determined the crystal structure of
the Ets domain of Ets-2. The structure, determined in complex
with a single EBS DNA oligonucleotide, unexpectedly contains
archetypes of both the autoinhibited and non autoinhibited
forms, allowing us to analyze the structural and conformation
differences that accompany autoinhibition. The association
and interfaces formed between molecules in the asymmetric
units give insights into novel aspects of the autoinhibitory
mechanism and cooperative binding.
EXPERIMENTAL PROCEDURES
Cloning and Overexpression—Plasmid DNA templates for
full-length human Ets-2 (IMAGE: 3852274) and full-length
murine Ets-1 (IMAGE: 40056547) were obtained from the
Mammalian Gene Collection (Source BioScience, Nottingham,
UK).
The fragments of Ets-2 and Ets-1 used in this study are: Ets-
2325–464 (Ets and autoinhibition domains, crystallized frag-
ment), Ets-2308–469 (Ets domain, autoinhibition domain and
N-terminal flanking sequence, used in electrophoretic mobility
shift assays (EMSAs)), Ets-2325–469 (Ets and autoinhibition
domains, used in EMSA), Ets-2360–464 (ETS domain, used in
EMSA), Ets-1280–440 (Ets domain, autoinhibition domain, and
N-terminal flanking sequence, used in EMSA), Ets-1300–440
(Ets and autoinhibition domains, used in EMSA), Ets-1331–440
(Ets domain, used in EMSA). The gene fragments were ampli-
fied by PCR and cloned into the pNIC28-Bsa4 expression vec-
tor, encompassing a tobacco etch virus protease-cleavable
N-terminal His tag MHHHHHHSSGVDLGTENLYFQ2SM),
as described elsewhere (25). Plasmids were transformed into
BL21(DE3)-R3-pRARE2, and cultures were grown in Ultra-
Yield baffled flasks (Thomson InstrumentCo.) inTerrific Broth
medium containing 50 g/ml kanamycin at 37 °C to an A600 of
2–3, at which point the cultures were cooled to 18 °C and
expression was induced by the addition of 0.1 mM isopropyl
-D-1-thiogalactopyranoside, with cells harvested 18 h after
induction.
Protein Purification—For purification of both the Ets-1 and
Ets-2 domains, cell pellets were thawed and resuspended in
buffer A (50 mM HEPES, pH 7.5, 500 mM NaCl, 5% glycerol, 10
mM imidazole, 0.5mMTris(2-carboxyethyl)phosphine) anddis-
rupted by sonication. Cell debris and nucleic acids were
removed by the addition of 0.15% polyethyleneimine, pH 7.5,
and centrifugation at 50,000  g for 1 h at 4 °C. The superna-
tants were applied to a 3-ml Ni2-iminodiacetic acid (Ni-IDA)
agarose immobilizedmetal ion affinity chromatography gravity
flow column, washed with wash buffer (buffer A with 30 mM
imidazole), and eluted with 5 column volumes of elution buffer
(buffer A with 300 mM imidazole). Proteins were incubated
overnight at 4 °C in the presence of tobacco etch virus protease
(1:40 mass ratio) while being dialyzed using 3.5-kDa molecular
weight cutoff snakeskin membrane (Thermo Fisher Scientific,
Rockford, IL) into buffer B (20 mM HEPES, pH 7.5, 500 mM
NaCl, 5% glycerol, 0.5 mM Tris(2-carboxyethyl)phosphine).
Tobacco etch virus protease and contaminating proteins were
removed by reapplication of dialyzed proteins to a Ni2-imino-
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diacetic acid agarose immobilized metal ion affinity chroma-
tography column (2-ml column volume). Proteins passing
through the column were pooled and concentrated using a
10-kDa molecular weight cutoff centrifugal concentrator to 1
ml before loading onto a HiLoad 16/60 Superdex S75 gel filtra-
tion column equilibrated in buffer B. Proteins were identified
by SDS-PAGE and confirmed by mass spectrometry, and con-
centrations were determined by absorbance measurement at
280 nm (Nanodrop) using the calculated molecular mass and
extinction coefficients.
Crystallization and Structure Determination—For crystalli-
zation of the Ets domain DNA complex, the oligonucleotides
ACCGGAAGTG and CACTTCCGGT were resuspended to
900 M in 10 mM Tris-HCl, pH 8.0, 50 mMNaCl, mixed in a 1:1
ratio, heated to 95 °C for 5 min in a heating block, and allowed
to cool slowly over several hours. The Ets-2 Ets domain protein
was concentrated to 300M (5mg/ml) andmixedwith an equal
volume of double-stranded DNA (1:1.5 molar ratio) before
being concentrated on a 3-kDamolecular weight cutoff centrif-
ugal concentrator to 15 mg/ml for crystallization. Sitting drop
vapor diffusion crystallization trials were set up with a Mos-
quito (TTP Labtech) crystallization robot. Crystals grew at
20 °C from conditions containing 0.1 M BisTris, pH 5.5, 0.25 M
NaCl, and 15% PEG 3350 and were transferred to a cryopro-
tectant solution consisting of well solution supplemented with
25% ethylene glycol before being loop-mounted and plunged
into a pool of liquid nitrogen. Diffraction data were collected at
Diamond Light Source beamline I02 and processed using XDS
(26), and the structure was solved by molecular replacement
using the programMOLREP (27) with the structure of the FEV
DNA complex (PDB ID 3ZP5) as a search model. Model build-
ing was performed using the program COOT (28) and refined
using and PHENIX REFINE (29). A summary of the data col-
lection and refinement statistics is found in Table 1.
ElectrophoreticMobility Shift Assays—The affinity and coop-
erativity of Ets-2 Ets domain DNA binding wasmeasured using
EMSAs. The probes consisted of the following oligonucleotide
sequences annealed to the complementary strands (the core Ets
binding sites are underlined): single site (ATCTCACCGGAA-
GTGTAGCA) and palindromes (4-bp, AGCGGAAGTACTT-
CCGGA; 5-bp, AGCGGAAGTGACTTCCGGA; 6-bp, AGC-
GGAAGTGCACTTCCGGA; 7-bp, AGCGGAAGTGACAC-
TTCCGGA; 8-bp, AGCGGAAGTGATCACTTCCGGA).
Radiolabeled double-stranded DNA probes were prepared
by incubating the forward strand oligonucleotides for 1 h at
37 °C with T4 polynucleotide kinase in the presence of
[-32P]ATP. Complementary (non-radiolabeled) oligonucleo-
tides were added, and the mixture was heated to 95 °C and
FIGURE 1. Structure of the Ets-2 Ets bound to DNA. A, schematic representation of the contents of the asymmetric unit of Ets-2; DNA crystals with Ets-2
molecules represented in the ribbon format. Crystallographic symmetry mates are shown in gray, and dotted lines represent stacking of blunt ends of DNA
oligonucleotides, which form a pseudo-continuous DNA molecule in the crystal. B, stereo view of the overall structure of the Ets-2 Ets domain with secondary
structure elements labeled. The three chains are superposed and color-coded as for A. C, stereo view of the interaction of Ets-2 with DNA with key interacting
residues and DNA molecules shown in the stick format.
Crystal Structures of Human Ets-2
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allowed to cool slowly to room temperature. The double-
stranded DNA probes were purified before use on a Bio-Rad P6
micro-biospin column. EMSAs were performed by incubating
radiolabeled probe (at a concentration of 0.1 nM for Ets-2 and
0.02 nM for Ets-1) with protein titrated by serial dilution. The
buffer was 50 mM Tris-HCl, pH 7.5, 25 mM NaCl, 50 mM L-ar-
ginine-HCl, pH 7.5, 0.5 mM EDTA, 0.1% Tween 20, 2 mMDTT,
and 5% glycerol (inclusion of arginine in the buffer prevented
the precipitation of protein-DNA complexes). Reactions were
performed for 15 min at room temperature, and 5 l of each
reaction was mixed with loading dye to 0.25% and resolved by
12% native polyacrylamide gel electrophoresis in Tris borate
EDTA buffer at 180 V for 1 h on ice. Gels were visualized using
phosphorimaging, quantitation was performed using quantity
one 1-D analysis software (Bio-Rad), and apparent dissociation
constants were calculated using a sigmoidal four-parameter
logistic nonlinear regression model in PRISM (GraphPad).
Modeling of Ets-2 on Palindromic DNA Substrates—To
assess potential interactions between Ets-2 molecules on the
various palindromic DNA substrates, we have superposed
chain A of the Ets-2 structure as a rigid body onto successive
positions on the pseudo-contiguous DNA duplex (formed by
chains E, F, H, and I in the Ets-2 structure) as dictated by the
spacing requirements of the GGAAmotifs of the Ets-2 consen-
sus sequence using the program COOT (28). For the case of
substrates with the GGAA motifs separated by 4 bp, the result
of this superposition was found to be almost identical to the
arrangement of the chains in the Ets-1 stromelysin-1 promoter
DNA complex (20).
RESULTS
Structure of the Ets-2 DNA Complex—Crystals of the Ets-2
DNA complex were obtained with an Ets-2 construct spanning
residues 325–464, including the N-terminal (HI-1 and HI-2)
and C-terminal (H4 and H5) autoinhibitory regions and the
DNA oligonucleotides 5-ACCGGAAGTG and 5-CACTTC-
CGGT. The crystals belong to a primitive monoclinic crystal
system, space group P 21, and diffracted to 2.5Å resolutionwith
3 copies of Ets-2 and three 10-bp DNA duplexes in the asym-
metric unit. The structure was solved by molecular replace-
ment using the structure of FEV DNA complex (PDB ID 3ZP5)
as a search model. The three DNA duplexes in the asymmetric
unit pack with base-stacking interactions that are extended
through contacts with symmetry mates to form a pseudo-con-
tiguous double helix spanning the length of the crystal (Fig. 1A).
The electron density map is of overall high quality for both
DNAand protein chains, with the finalmodel containing 301 of
a possible 417 protein residues, and was refined to a crystallo-
graphic Rfactor of 0.235 (Rfree of 0.255). A summary of the data
collection and refinement statistics can be found in Table 1.
An examination of the three Ets-2molecules in the asymmet-
ric unit reveals that, although they all share the same core Ets
family fold and interact with double-stranded DNA in a similar
manner, the autoinhibitory regions are significantly different,
beingwell ordered in chainA but almost completely disordered
in the other two chains (D andG) (Fig. 1B). The core Ets family
fold, common to all chains in the asymmetric unit, consists of a
four-stranded antiparallel-sheet, (strand order1,2,4,3)
flanked on one side by three -helices with an additional short
helix immediately preceding the first strand, which is of inter-
mediate character ( and 310). The recognition helix (H3)
inserts deep into the major groove of the DNA and forms a
number of base pair-specific interactions with the DNA, with
additional contacts to the DNA backbone being formed from
residues in the C terminus of H2, the H2-H3 loop, 3, and the
3-4 loop (Fig. 1C). Overall the protein DNA interface is very
similar to that described in other structural investigations of Ets
family proteins (12) and as such is not described in detail here.
Structure of the Autoinhibited Form—In chain A the entire
autoinhibitory module can be seen to form a complete folded
helical structure and associates with the core of the Ets domain
via an extensive interface formed by H1 and the 1-2 loop.
The contact area for the interface is 790 Å2 with 7 hydrogen
bonds being formed between the core and autoinhibitory mod-
ule, although the majority of the contacts are hydrophobic in
nature, with the core Ets domain providing several aromatic
residues (Trp-366, Leu-370, Leu-373, Trp-384, Trp-389, and
Phe-442) that contact predominantly branched chain amino
acids on the autoinhibitory module (Ile-349, Leu-354, Leu-446,
and Leu-457) (Fig. 2A). The HI-1 helix, which was suggested to
undergo a structural transition from ordered to disordered
upon DNA binding (8, 9), is well ordered and forms a helical
secondary structure that packs against the C-terminal ends of
helices H4 and HI-2, burying two predominant aromatic resi-
dues (Phe-331 and Tyr-334). Overall the structure of chain A,
hereinafter referred to as the autoinhibited form, is generally
TABLE 1
Data collection, phasing, and refinement statistics
Data are provided for the ETS DNA complex.
Data collection statistics
Space group P 21
Cell dimensions, a, b, c (Å) 36.7, 97.0, 83.8
Angles , ,  (°) 90, 97.1, 90
Wavelength (Å) 0.9765
Resolution (Å) 48-2.5 (2.62-2.5)
Rmerge
a 0.04 (0.67)
Rp.i.m.
b 0.03 (0.53)
I/I 16.3 (2.0)
Completeness (%) 99.6 (99.9)
Multiplicity 3.8 (3.9)
No. unique reflections 20,136 (2707)
Refinement statistics
Resolution 48-2.5 (2.56-2.5)
Rwork/Rfree (%) 23.4/25.6 (32.5/33.8)
No. atoms
Protein 2,459
DNA 1,212
Ligand/ion 0
Waters 33
Average B factors (Å2)
All atoms 67.9
Protein 78.5
Ligand/ion
DNA 63.7
Waters 53.2
Wilson B 63.4
Root mean square deviations
Bond lengths (Å) 0.003
Bond angles (°) 0.79
Ramachandran plot
Favored (%) 97
Allowed (%) 100
PDB ID 4BQA
a Rmerge  hkliIi  Im/hkliIi where Ii and Im are the observed intensity and
mean intensity of related reflections, respectively.
b Rp.i.m.  hkl 	(1/n  1) i
n  1Ii  Im/hkliIi.
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similar to the NMR structure of the autoinhibited Ets-1 (7)
(PDB ID 1R36) (1.7 Å root mean square deviation over 123
aligned C atoms). The most notable difference is the HI-1–
HI-2 loop (residues 338–346), which in Ets-2 contains a single
amino acid insertion (Pro-341), and is in a different conforma-
tion, forming an extended solvent-exposed loop with a single
salt bridge formed between Arg-338 and Glu-343. In contrast,
the equivalent region of Ets-1 folds back, forming interactions
with the N-terminal region of HI-2 (Fig. 2B). It is interesting to
note that the negatively charged Glu-343 is not conserved in
Ets-1 (the equivalent residue being Asn-315) and, instead of
forming a salt bridge, forms a hydrogen bondwith amain chain
residue withinHI-2 (Ala-324). Other smaller differences can be
observed in the relative positioning of HI-1, which is shifted by
20°, and the conformation of the 3-4 loop, although the
latter makes a number of contacts to the phosphodiester back-
bone of the DNA in the Ets-2 structure.
Structure of the Non-autoinhibited Form—For the remaining
chains in the asymmetric unit (chain D and G) the entire auto-
inhibitorymodulewas either completely or partially disordered
FIGURE 2. Structure of the autoinhibited form of Ets-2. A, schematic model of the interface between the core Ets domain (cyan) and the autoinhibitory
module (gray). Key hydrophobic interacting residues are labeled and shown in the stick format. B, comparison of Ets-2 (Chain A, cyan) with the autoinhibited
form of Ets-1 (shown in gray), with residues possibly contributing to the conformational difference of the HI-1-HI-2 loop shown in the stick format. C, 2Fo  1Fc
(shown in blue) and Fo  Fc (shown in green) electron density maps contoured at 1.0 and 2.5 , respectively, showing the partial electron density for the
autoinhibitory module in the vicinity of chain D (shown in red). A copy of chain A is shown superposed for reference. D, stereo view of a comparison of the three
Ets-2 chains in the asymmetric unit shown in the schematic representation with key residues forming intramolecular salt bridges in chain A but not in the other
two chains highlighted in the stick format.
Crystal Structures of Human Ets-2
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and was not modeled in final structure. Residual electron den-
sity, of insufficient quality to build into, can be observed in
regions that would correspond to the expected positions of
H1–2, H4, and H5 in chain D (Fig. 2C), suggesting that the
disorder in this chain is less extensive. The remainder of the
protein corresponding to the Ets core (residues 361–444) is
overall highly similar to that of the autoinhibited form (0.6 Å
rootmean square deviation
85 alignedC residues), although
there are some regions of significant difference between the two
forms. Most notably the H1-1 and the 1-2 loops, which in
the autoinhibited form contact the HI-1 and HI-2 loop and H5,
respectively, adopt different main chain conformations. There
are also a large number of side-chain residues that transition
from being ordered in the autoinhibited form to being disor-
dered in the other two chains; a significant proportion of these
(Asp-387, Arg-401, Arg-406, Lys-436, and Arg-441) participate
in intramolecular salt bridges in the autoinhibited form (Fig.
2D). Although distant from the recognition helix (H3), the even
distribution of these residues around the molecule together
with the fact that they generally link distant elements of second-
ary structure suggest that the formation of these interactions
may be a way in which the presence/absence of the autoinhibi-
tory module is transmitted allosterically. Comparing the crys-
tallographic B factor values for the conserved regions of chains
A, D, and G reveal a general pattern of significantly higher B
values for regions contacting the autoinhibitory module in
chains D and G, whereas the recognition helix is relatively
unchanged (Fig. 3A).
An examination of the environment of the various chains in
the asymmetric unit provides an explanation as to why two
different forms are present. Although chain A does not form
any significant interfaces with other Ets-2 molecules, chains D
and G are closely associated, with each other being located on
adjacent major grooves on the same face of the DNA in a man-
ner highly reminiscent of other dimeric helix turn helix tran-
scription factors. The twoDNAmolecules that formpart of this
interface stack their blunt ends togetherwith almost exactly the
same geometry as a continuous DNA double helix (Fig. 3B).
Thus the arrangement of chains D and G in the crystal is very
close to what would be expected from a palindromic DNA
sequence in which the Ets binding sites are separated by six
bases.
Autoinhibition Properties of Ets-2—Given the fact that we
observe the autoinhibited form of Ets-2 bound to the specific
recognition sequence in the Ets-2 structure, we decided to
investigate the autoinhibitory properties of Ets-2 and compare
this activity with Ets-1. We have measured the binding affinity
of three different length Ets-2 constructs on a single site Ets-2
consensus DNA binding sequence directly alongside the equiv-
alent constructs of Ets-1 (for technical reasonswe have used the
murine Ets-1 gene, which differs from the human gene in only
one position, S288Y, over the length of the constructs used).
These constructs correspond to the equivalent of viral Ets-1
(lacking the entireN-terminal autoinhibitorymodule), the con-
struct used for Ets-2 crystallization, and a longer construct con-
taining an additional 20 residues N-terminal to HI-1 that are
believed to be disordered and contain a serine-rich sequence.
First, the overall binding affinity of the shortest constructs,
which should not be subject to any kind of autoinhibition, is
significantly higher for Ets-1 than Ets-2, with an4-fold differ-
ence in affinity when tested on the same substrate (0.1  0.06
nM versus 0.4  0.04 nM). Given the two proteins share 90%
sequence identity over this region and none of the substitutions
could be expected to have any direct effect on DNA binding
from the crystal structure, these differences indicate that some
subtle aspects of the energetics of the interaction of Ets-1 and
Ets-2 with DNA are not understood.
Wehave also found significant differences betweenEts-1 and
Ets-2 in the nature of their autoinhibition. In Ets-1 two mech-
anisms of autoinhibition have been found to be present, a mod-
est effect caused by the association of the autoinhibitory mod-
ule (2–3-fold inhibition) (4–6, 8, 9) and a more marked
inhibition provided by an intrinsically disordered serine-rich
sequence N-terminal to this (13–15). Consistent with previous
FIGURE 3. A, stereo view of the Ets-2 Ets domain in complex with DNA, showing the differences in B-factor between chain A and chains D and G (average of the
two values used for calculation) plotted on a per-residue basis onto the structure. B, comparison of the geometry of the pseudo-continuous DNA strand, formed
by the interface of the blunt ends of DNA molecules bound to chains D and G in the Ets-2 structure, with a similar length of ideal B-form DNA.
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studies, wewere able to demonstrate both types of inhibition on
Ets-1 (5- and 2.6-fold, respectively), but only the latter mech-
anism of inhibition seems to apply to Ets-2 (8-fold inhibition;
Fig. 4).
Cooperative DNA Binding by Ets-2—Cooperative binding to
palindromic EBS repeats has been the focus of numerous stud-
ies using both Ets-2 andEts-1 (9, 16, 20, 21), with themajority of
studies focusing on palindromic arrangements such as that in
the stromelysin promoter in which the core GGA(A) motif is
separated by four base pairs. Given the differences observed in
the autoinhibition between Ets-1 and Ets-2 and the finding of
an arrangement in the crystal structure that mimics a palin-
dromic arrangement separated by 6 bp, we have decided to
perform electrophoretic mobility shift assays using the short
and medium length Ets-2 constructs. These were incubated
with a variety of DNA substrates containing inverted repeats of
FIGURE 4. Analysis of the autoinhibition of Ets-2. A, representative electrophoretic mobility shift assays of three Ets-2 constructs binding to DNA substrates
with a single copy of the consensus Ets-2 binding sequence. The constructs from left to right correspond to Ets-2360 – 464 (core Ets domain only), Ets-2325– 464
(core Ets and autoinhibition domains), and Ets-2308 – 469 (core, autoinhibition and N-terminal serine-rich sequence). B, representative electrophoretic mobility
shift assays of the equivalent domains of Ets-1 with the same DNA sequence. C, quantification of the data presented in panel A; error bars are plotted as S.E.
from at least three independent experiments, and the data are plotted for Kd
app. D, quantification of the Ets-1 binding data presented in panel B.
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the consensus Ets bindingmotif separated by a variable 4–8-bp
spacer.
The binding of Ets-2 to substrates with a palindromic
arrangement was different between the two constructs, with
the Ets-2 325–469 construct binding exclusively in a coopera-
tivemanner (forming a super-shifted band on the gel, which we
presume represents an Ets-2DNAcomplexwith 2:1 stoichiom-
etry) to substrates with a 4-bp spacer, and exclusively in a
non-cooperative manner to substrates with a 5-bp spacer
(Fig. 5A). Substrates containing 6- or 7-bp spacers appeared
to be able to form both single and super-shifted species with
both constructs (Fig. 5A). We performed a crude quantifica-
tion of these data, taking the disappearance of the free DNA
as a proxy for the total binding, and the appearance of single-
and double-shifted bands to represent 1:1 and 2:1 interaction
stoichiometries (Fig. 5, A and B). Although the data do not
reach saturation it is clear that some degree of cooperativity
is in effect in the binding of Ets-2 to the 6-bp substrate,
which clearly shows significant amounts of the double-
shifted band at lower protein concentrations than the 7-bp
substrate (which we infer to be independent binding events).
Data for substrates with 8-bp spacer sequences were found
FIGURE 5. Analysis of cooperative DNA binding by Ets-2. A, cooperative DNA binding properties of Ets-2325– 464 (core Ets and autoinhibition domains)
binding to a variety of DNA substrates with palindromic repeats, with a variable length spacer between the GGAA core. DNA sequences used are shown on the
top, representative electrophoretic mobility shift assays are shown in the center, and a quantification plot, which expresses the amounts of free DNA (red
triangles), single-shifted species (black circles), and double-shifted species (black squares) as a percentage of the total material in each lane, is shown on the
bottom. Error bars are plotted as S.E. from two independent experiments, although additional biological replicates were performed with the same results. B,
cooperative DNA binding properties of Ets-2360 – 464 (core Ets domain only). The data are presented as for A with the DNA substrate used being the same as that
used above.
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to be almost identical to the 7-bp data and for the sake of
brevity are not shown. The extent of the cooperativity on the
6-bp substrate is significantly less marked than observed
with the 4-bp substrate, and the fact that it is observed
(although possibly to different extents) in both constructs
suggests it is not dependent on residues in the autoinhibitory
region. It is important to note, however, that in all cases the
apparent affinity for the palindromic sequences is signifi-
cantly lower than for the single-site substrate, perhaps indi-
cating a sequence dependence on DNA binding.
Using the DNA-bound structures of Ets-2 as a guide it is
possible to model the potential intermolecular interactions
formed on these substrates. In agreement with observations
fromcrystal structures of Ets-1 in complexwith the stromelysin
promoter DNA (19, 20), positioning two copies of Ets-2 on
substrates with a 4-bp spacer reveals a small but significant
protein interface area (370 Å2) created by the HI-2-H1 loop
contacting the H2-H3 loop in the adjacent chain, with the
potential to form the same hydrogen bond between Asn-408
and Gly-361 as found in the structure of Ets-1 bound to the
stromelysin promoter (19, 20) (Fig. 6A). Crucially this interface
is unlikely to be formed in the shorter construct which lacks
HI-1 and HI-2. Positioning Ets-2 on substrates with a 5-bp sep-
aration reveals significant steric clashes that occur between the
two molecules involving primarily HI-1 and HI-2 but also
regions of the core Ets domain (Fig. 6B), explaining the com-
plete lack of formation of the super-shifted band in either con-
struct. The likely arrangement of Ets-2 on a substrate with
binding sites separated by 6 bp is revealed by chains D and G in
the Ets-2 structure, and positioning two copies of the autoin-
hibited form onto these chains reveals a steric clash occurs
between the C-terminal ends of HI-1 and HI-2 and their equiv-
alents on the neighboring subunit (Fig. 6C). Nevertheless the
fact that this arrangement is present in the Ets-2 crystals (which
were obtained using the longer Ets-2 325–469 construct) and
appears, from the EMSA analysis, to form preferentially in the
longer construct but not the short, suggests that this clash can
be accommodated presumably by the introduction of disorder
in the N-terminal inhibitory module. Thus the structure sug-
gests that there is a direct steric requirement for at least one of
the autoinhibitory modules to be disordered when binding to
this type of substrate.
We have also noticed through this superposition that, due to
the fact that equivalent regions of the HI-2-H1 loop overlap
close to residues Gly-361 and Pro-362, it is possible that the
N-terminal autoinhibitory modules may adopt a domain-
swapped conformation (Fig. 7A). Although the electron density
is too poor to determinewhether this is happening in the crystal
(Fig. 7B), the fact that numerous examples of domain swapping
have also occurred in various Ets-1 structures suggests that this
phenomenon may be worthy of a more detailed investigation.
Modeling of Ets-2 structures bound to substrates with Ets bind-
ing sites separated by seven ormore base pairs reveals that there
is no possibility of forming a significant protein-protein inter-
face, and thus the binding at the two sites would be expected to
be largely independent.
DISCUSSION
Previous structural studies of the closely related Ets-1 estab-
lished amodel for autoinhibition inwhich the unfolding ofHI-1
upon binding DNA (a process that presumably has a positive
G) reduces the affinity of the autoinhibited form. It had been
presumed that this mechanism may also apply to Ets-2; how-
ever, we failed to demonstrate any noticeable difference in
FIGURE 6. Modeling of the Ets-2 structures on to three DNA substrates in which the core GGA(A/T) motif is separated by 4 (A), 5 (B), and 6 base pairs (C)
viewed with the 2-fold symmetry axis vertical (upper row) and in the plane on the page (lower row).
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DNA binding affinity on single Ets binding sites between Ets
domain constructs with and without the N-terminal autoin-
hibitory regions. In contrast we have shown an 5-fold reduc-
tion in affinity when comparing the equivalent constructs of
Ets-1, which is in agreement with previous studies (4–6, 8, 9,
30). Comparison of the twoDNAcomplex structures reveals an
almost identical protein DNA interface, with the sequence of
the recognition helix and all DNA contacting residues being
completely conserved between the two proteins, indicating that
the differences in affinity may come from the dynamics of the
association of the autoinhibitory module. Instead the serine-
rich region upstream of the N-terminal autoinhibitory region,
which has been shown to play a role in Ets-1 inhibition (10, 13,
15), appears to be the sole region responsible for the autoinhi-
bition of Ets-2, causing an 10-fold inhibition. It is possible
that this inhibition may be further enhanced by phosphoryla-
tion as is the case for Ets-1 (15).
We were also surprised to find two distinct forms for the Ets
domain of Ets-2 in our crystals, one in which the N-terminal
autoinhibitory regions are largely disordered and another with
the entire autoinhibitory region ordered. The fact that both of
these are bound to DNA and appear to make an identical pro-
tein DNA interface again suggests that the establishedmodel of
Ets-1 autoinhibition is not directly applicable to Ets-2. Never-
theless a comparison of the two forms of Ets-2 gives insights
into how the presence or absence of the autoinhibitory module
may be transmitted to the rest of the Ets domain, with a number
of intramolecular salt bridges formed in the autoinhibited form
(presumably stabilized by the presence of the autoinhibitory
module) which are evenly distributed throughout the molecule
and may serve to subtly alter the conformation or dynamics of
the residues forming the DNA interface.
We have also investigated the cooperativity of DNA binding
by Ets-2 and in this respect find the activity of Ets-2 to be largely
similar to Ets-1. A significant cooperative DNA binding effect
was observed on DNA substrates where the Ets binding sites
were separated by 4 bp, which was dependent on the presence
of the N-terminal autoinhibitory helices. The length depen-
dence of theDNAspacerwas also investigated, and it was found
that Ets-2was unable to bind cooperatively to sites separated by
5 bp. Some degree of cooperativity in binding was observed for
sites separated by 6 bp, which in contrast to the situation in the
4-bp-spaced sequences was effected by, but not dependent on
the presence of the autoinhibitory region. Modeling of Ets-2
onto these various substrates revealed the possible mechanism
bywhich cooperativity is conferred due to the potential to form
favorable/unfavorable interactions and order-disorder transi-
tions of the N-terminal autoinhibitory helices.
Protein Data Bank Accession Numbers—Atomic coordinates
and structure factors were deposited in the Protein Data Bank
with the accession number PDB 4BQA (Ets-2-DNA).
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